106 related articles for article (PubMed ID: 17088683)
1. 18F-FDG PET imaging in assessing exudative pleural effusions.
Duysinx BC; Larock MP; Nguyen D; Corhay JL; Bury T; Hustinx R; Louis R
Nucl Med Commun; 2006 Dec; 27(12):971-6. PubMed ID: 17088683
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
Duysinx B; Nguyen D; Louis R; Cataldo D; Belhocine T; Bartsch P; Bury T
Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
[TBL] [Abstract][Full Text] [Related]
5. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN
Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665
[TBL] [Abstract][Full Text] [Related]
6. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
[TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-fluorodeoxyglucose PET/CT findings in pleural effusions of patients with known cancer. A cytopathological correlation.
Letovanec I; Allenbach G; Mihaescu A; Nicod Lalonde M; Schmidt S; Stupp R; Fitting JW; Boubaker A; Ris HB; Prior JO
Nuklearmedizin; 2012; 51(5):186-93. PubMed ID: 22584348
[TBL] [Abstract][Full Text] [Related]
8. FDG PET of pleural effusions in patients with non-small cell lung cancer.
Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
[TBL] [Abstract][Full Text] [Related]
9. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
10. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction.
Sugawara Y; Zasadny KR; Neuhoff AW; Wahl RL
Radiology; 1999 Nov; 213(2):521-5. PubMed ID: 10551235
[TBL] [Abstract][Full Text] [Related]
11. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Schaffler GJ; Wolf G; Schoellnast H; Groell R; Maier A; Smolle-Jüttner FM; Woltsche M; Fasching G; Nicoletti R; Aigner RM
Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
[TBL] [Abstract][Full Text] [Related]
15. Malignant pleural mesothelioma: utility of 18 F-FDG PET.
Spitilli MG; Treglia G; Calcagni ML; Giordano A
Ann Ital Chir; 2007; 78(5):393-6. PubMed ID: 18338546
[TBL] [Abstract][Full Text] [Related]
16. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology.
Gerbaudo VH; Sugarbaker DJ; Britz-Cunningham S; Di Carli MF; Mauceri C; Treves ST
J Nucl Med; 2002 Sep; 43(9):1144-9. PubMed ID: 12215551
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
18. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction.
Kim CK; Gupta NC; Chandramouli B; Alavi A
J Nucl Med; 1994 Jan; 35(1):164-7. PubMed ID: 8271040
[TBL] [Abstract][Full Text] [Related]
19. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of CT attenuation values of focal 18F-FDG avid breast lesions detected on whole-body PET-CT in postoperative breast cancer patients.
Plaza MJ; Collado-Mesa F; Bokhoor J; Alperin N; Yepes MM
Breast J; 2014; 20(3):235-42. PubMed ID: 24750508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
